Arif Bilal

Arif Bilal is listed in filings as Chief Operations Officer at KalVista Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 21, 2026, including sale activity. Recent filings connect the profile to KalVista Pharmaceuticals, Inc. (KALV) and Sarepta Therapeutics, Inc. (SRPT). The current snapshot covers public activity from Jun 25, 2024 to Jan 21, 2026. Reported amounts are shown as $1.1M to $52.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.